At a glance
ClinicalIndex Comparison RecordN/ACompleted· 185 enrolled
Drug / intervention
Erythritol drink +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Gastrointestinal Tolerance of Erythritol-containing Beverages in Young Children
In Brief
A clinical study evaluating Erythritol drink and Placebo drink for Gastrointestinal and Tolerance. Completed, enrolled 185 participants across 3 sites.
Detailed Summary
Purpose of this study: assess the maximum tolerated bolus dose of erythritol, delivered in a clear beverage, compared with placebo (saccharose) in 4-6 year old children.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastrointestinal, Tolerance
CountriesFrance
CollaboratorsBiofortis Mérieux NutriSciences
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2006
Primary CompletionJul 2009
Study CompletionJul 2010
First PostedDec 2013
TodayJul 2026
First PostedDec 20, 2013
Enrollment StartMar 1, 2006
Primary CompletionJul 1, 2009
Study CompletionJul 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 12.5 years ago
Interventions
Erythritol drinkother
Placebo drinkother